Advertisement
Screener

Haemonetics Corporation (HAE) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

2.6 / 5 stars · 48/93 Roast Me

Haemonetics Corporation Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

Haemonetics Corporation (HAE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 1.40% for the 9-month period ending 2015-12-26, per its 10-Q filed 2016-02-02.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2016-02-02

  • Haemonetics Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-06-27 was 1.75%, a 6.71% increase year-over-year.
  • Haemonetics Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2014-09-27 was 1.80%, a 28.57% increase year-over-year.
  • Haemonetics Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2014-06-28 was 1.64%, a 16.31% increase year-over-year.
  • Haemonetics Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2013-09-28 was 1.40%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month
2015-12-261.40%
10-Q · filed 2016-02-02
2015-09-261.65%
10-Q · filed 2015-11-04
2015-06-271.75%
10-Q · filed 2015-07-30
2014-12-271.75%
10-Q · filed 2016-02-02
2014-09-271.80%
10-Q · filed 2014-11-04
1.80%
10-Q · filed 2015-11-04
2014-06-281.64%
10-Q · filed 2015-07-30
2013-12-281.30%
10-Q · filed 2015-02-05
2013-09-281.40%
10-Q · filed 2014-11-04
1.40%
10-Q · filed 2013-10-30
2013-06-291.41%
10-Q · filed 2014-07-31
2012-12-290.72%
10-Q · filed 2014-01-30
2012-09-290.62%
10-Q · filed 2013-10-30
2012-06-300.92%
10-Q · filed 2013-08-02
2011-12-311.12%
10-Q · filed 2013-02-01
2011-10-011.60%
10-Q · filed 2012-11-07
2011-07-021.65%
10-Q · filed 2012-08-08
2011-01-011.89%
10-Q · filed 2012-02-06
2010-10-022.43%
10-Q · filed 2011-11-03
2010-07-032.64%
10-Q · filed 2011-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55